Last reviewed 2026-05-15 · How we verify

clopidogrel combined with rivaroxaban arm

Shenyang Northern Hospital · FDA-approved active Small molecule Quality 0/100

clopidogrel combined with rivaroxaban arm is a Small molecule drug developed by Shenyang Northern Hospital. It is currently FDA-approved. Also known as: clopidogrel combined with rivaroxaban.

Clopidogrel combined with rivaroxaban, marketed by Shenyang Northern Hospital, holds a unique position in the cardiovascular and anticoagulant market. The key composition patent expiring in 2028 provides a significant period of exclusivity, enhancing the drug's competitive advantage. However, the lack of detailed primary trial results and revenue data poses a primary risk, potentially limiting investor confidence and market adoption.

At a glance

Generic name	clopidogrel combined with rivaroxaban arm
Also known as	clopidogrel combined with rivaroxaban
Sponsor	Shenyang Northern Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

clopidogrel combined with rivaroxaban arm CI brief — competitive landscape report
clopidogrel combined with rivaroxaban arm updates RSS · CI watch RSS
Shenyang Northern Hospital portfolio CI

Frequently asked questions about clopidogrel combined with rivaroxaban arm

What is clopidogrel combined with rivaroxaban arm?

clopidogrel combined with rivaroxaban arm is a Small molecule drug developed by Shenyang Northern Hospital.

Who makes clopidogrel combined with rivaroxaban arm?

clopidogrel combined with rivaroxaban arm is developed and marketed by Shenyang Northern Hospital (see full Shenyang Northern Hospital pipeline at /company/shenyang-northern-hospital).

Is clopidogrel combined with rivaroxaban arm also known as anything else?

clopidogrel combined with rivaroxaban arm is also known as clopidogrel combined with rivaroxaban.

What development phase is clopidogrel combined with rivaroxaban arm in?

clopidogrel combined with rivaroxaban arm is FDA-approved (marketed).

Manufacturer: Shenyang Northern Hospital — full pipeline
Also known as: clopidogrel combined with rivaroxaban
Compare: clopidogrel combined with rivaroxaban arm vs similar drugs
Pricing: clopidogrel combined with rivaroxaban arm cost, discount & access